Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this study is to evaluate the efficacy and safety of 24 weeks memantine add-on treatment to risperidone for the treatment of negative symptomatology and cognitive impairment in patients with chronic schizophrenia.
Epistemonikos ID: 8a5b2f0c7d87c1bcb7d8464d972521423b644531
First added on: May 04, 2024